Sarepta Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2009 | -106.5% | -106.5% | — |
| FY2010 | 1,142.2% | 3,300.2% | -70.0% |
| FY2011 | -7.5% | -7.1% | -4.3% |
| FY2012 | -98.1% | -96.8% | -59.2% |
| FY2013 | -45.3% | -45.0% | -38.4% |
| FY2014 | -54.8% | -54.5% | -46.0% |
| FY2015 | -115.6% | -101.3% | -80.4% |
| FY2016 | -79.4% | -75.4% | -63.0% |
| FY2017 | -6.4% | -4.2% | -3.9% |
| FY2018 | -35.1% | -24.9% | -22.0% |
| FY2019 | -87.4% | -87.4% | -39.2% |
| FY2020 | -72.7% | -72.7% | -18.6% |
| FY2021 | -45.1% | -28.1% | -13.3% |
| FY2022 | -182.7% | -36.5% | -22.5% |
| FY2023 | -62.4% | -25.6% | -16.4% |
| FY2024 | 15.4% | 8.8% | 5.9% |
| FY2025 | -62.5% | -36.2% | -21.3% |